中興商業(000715.SZ):將打造獨有的恐龍IP,陸續開發周邊衍生產品
格隆匯12月20日丨中興商業(000715.SZ)在投資者關係活動上表示,恐龍博物館項目是公司全資子公司瀋陽中興商業管理諮詢有限責任公司與朝陽侏羅紀樂園文化旅遊產業發展有限公司成立合資公司,共同打造的集“遊、學、研、娛”為一體的“商業+博物館”新複合業態。首個博物館—“瀋陽·中興恐龍博物館”坐落在中興商業總店7樓,展陳面積3000餘平方米,通過360度沉浸式空間、Cosplay、線上線下研學等講述遼寧的恐龍故事,預計將於2024年12月末開放。未來視項目運作情況對外複製推廣,同時還將打造獨有的恐龍IP,陸續開發周邊衍生產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.